Susquehanna International Group’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-26,500
Closed -$444K 13089
2025
Q3
$444K Buy
+26,500
New +$397K ﹤0.01% 9232
2023
Q4
Sell
-10,200
Closed -$130K 12913
2023
Q3
$130K Buy
+10,200
New +$140K ﹤0.01% 10707
2023
Q2
Sell
-54,500
Closed -$813K 12712
2023
Q1
$813K Buy
54,500
+38,100
+232% +$577K ﹤0.01% 7368
2022
Q4
$244K Sell
16,400
-25,700
-61% -$419K ﹤0.01% 9623
2022
Q3
$695K Sell
42,100
-87,500
-68% -$1.76M ﹤0.01% 7586
2022
Q2
$2.72M Buy
129,600
+110,800
+589% +$2.26M ﹤0.01% 4249
2022
Q1
$441K Buy
18,800
+6,900
+58% +$169K ﹤0.01% 9293
2021
Q4
$324K Sell
11,900
-29,400
-71% -$787K ﹤0.01% 10293
2021
Q3
$1.17M Sell
41,300
-5,700
-12% -$174K ﹤0.01% 7144
2021
Q2
$1.42M Sell
47,000
-1,300
-3% -$38.4K ﹤0.01% 6815
2021
Q1
$1.23M Sell
48,300
-11,800
-20% -$302K ﹤0.01% 7176
2020
Q4
$1.48M Sell
60,100
-56,900
-49% -$1.07M ﹤0.01% 5778
2020
Q3
$1.91M Buy
117,000
+70,600
+152% +$1.31M ﹤0.01% 4717
2020
Q2
$793K Buy
46,400
+7,700
+20% +$114K ﹤0.01% 6412
2020
Q1
$450K Sell
38,700
-22,900
-37% -$472K ﹤0.01% 7154
2019
Q4
$1.71M Sell
61,600
-23,800
-28% -$597K ﹤0.01% 4583
2019
Q3
$1.93M Buy
85,400
+46,400
+119% +$1.06M ﹤0.01% 4270
2019
Q2
$984K Buy
39,000
+9,700
+33% +$261K ﹤0.01% 5693
2019
Q1
$796K Buy
29,300
+12,500
+74% +$419K ﹤0.01% 5442
2018
Q4
$554K Sell
16,800
-33,500
-67% -$1.35M ﹤0.01% 5823
2018
Q3
$2.35M Sell
50,300
-4,200
-8% -$193K ﹤0.01% 3741
2018
Q2
$2.36M Buy
54,500
+12,300
+29% +$589K ﹤0.01% 3743
2018
Q1
$2.35M Buy
42,200
+12,700
+43% +$696K ﹤0.01% 3622
2017
Q4
$1.58M Sell
29,500
-12,100
-29% -$571K ﹤0.01% 4357
2017
Q3
$1.79M Buy
41,600
+1,000
+2% +$47.5K ﹤0.01% 4112
2017
Q2
$2.45M Buy
40,600
+24,000
+145% +$1.42M ﹤0.01% 3522
2017
Q1
$1.15M Sell
16,600
-24,300
-59% -$1.69M ﹤0.01% 4831
2016
Q4
$2.73M Buy
40,900
+6,100
+18% +$397K ﹤0.01% 3430
2016
Q3
$2.31M Buy
34,800
+8,000
+30% +$547K ﹤0.01% 3320
2016
Q2
$1.94M Sell
26,800
-14,900
-36% -$1.02M ﹤0.01% 3625
2016
Q1
$2.69M Buy
41,700
+800
+2% +$53.1K ﹤0.01% 3224
2015
Q4
$2.93M Buy
40,900
+34,900
+582% +$2.58M ﹤0.01% 3325
2015
Q3
$461K Sell
6,000
-2,500
-29% -$202K ﹤0.01% 7276
2015
Q2
$630K Buy
8,500
+1,200
+16% +$86.4K ﹤0.01% 7169
2015
Q1
$529K Sell
7,300
-43,000
-85% -$2.99M ﹤0.01% 6991
2014
Q4
$3.33M Sell
50,300
-10,600
-17% -$647K ﹤0.01% 3555
2014
Q3
$3.34M Buy
60,900
+11,100
+22% +$630K ﹤0.01% 3706
2014
Q2
$2.9M Buy
49,800
+35,600
+251% +$2.09M ﹤0.01% 3980
2014
Q1
$880K Sell
14,200
-31,300
-69% -$1.82M ﹤0.01% 5738
2013
Q4
$2.43M Sell
45,500
-8,100
-15% -$435K ﹤0.01% 3957
2013
Q3
$2.69M Sell
53,600
-107,400
-67% -$5.24M ﹤0.01% 3644
2013
Q2
$7.37M Buy
+161,000
New +$7.21M ﹤0.01% 2156

Other funds holding MD

Susquehanna International Group's MD Position: Q1 2026 in Review

Susquehanna International Group increased its Pediatrix Medical (MD) stake by 35% in Q1 2026, buying an estimated $302K and bringing the position to 56,210 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #7410.

Susquehanna International Group first reported a position in MD in Q2 2013 and has held it in 40 quarters since. The position peaked at $3.89M in Q3 2015. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Susquehanna International Group held 56,210 shares of Pediatrix Medical worth $1.2M as of Q1 2026.
  • Susquehanna International Group bought 14,515 Pediatrix Medical shares in Q1 2026, an estimated $302K.
  • Pediatrix Medical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7410 holding.
  • Susquehanna International Group first reported a position in Pediatrix Medical in Q2 2013 and has held it in 40 quarters since.
  • Susquehanna International Group's Pediatrix Medical position peaked at $3.89M in Q3 2015.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.